Conference TopicsConference Topics

• Plenary Session：New Landscape of Cell Therapy in China

  - New development in global cell therapy market

  - Status & trends in China market

  - Analysis of policies & regulations on cell therapy products

  - Challenges for commercialization

  - Breakthroughs and bottlenecks

• Session 1: Latest Researches and Clinical Advancement

  - Stem cell therapy & diseases

  - Stem cell & regenerative medicine

  - MSC clinical trial development

  - CAR-T cell therapy in hematologic cancers

  - UCAR-T

  - Solid Tumor

  - New target for cancer immunotherapy

  - Checkpoint inhibitor

• Session 2: Clinical Trials and IND Application

  - IND review principles

  - Quality control in cell manufacturing

  - Clinical trials design & management

  - IND application strategy

  - Efficacy and toxicity management

  - Top considerations when choosing CRO company

  - Panel discussion：Industry requirements for policies and regulations

• Session 3: Cell and Gene Therapy Technologies

  - Next generation CAR-T/CAR-NK/TCR-T therapy

  - New combined treatment

  - Gene editing new technologies

  - Oncolytic virus therapy

  - iPSC technology-based regenerative therapy

• Session 4: Commercialization Challenges

  - Commercialization roadmap of cell therapy products

  - Global patent application

  - New products R&D strategy

  - Homogenization of CAR-T products and solutions

  - Biomedical products life circle management

  - Pricing strategy

• Session 5: Manufacturing Technologies & Industry Chain

  - Intelligent cell manufacturing

  - Viral vector manufacturing

  - GMP& quality control

  - Innovative cell culture platform

  - Clinical cell products supply chain management

  - Cell storage & cold chain delivery

• Session 5: Investment Trends and Case Study

  - Analysis of investment trends in cell therapy industry

  - Success case & risk management

  - Investment & financing policies for SMEs

  - Sci-tech innovation board listing criteria

Conference Highlights Conference Highlights

Multi-Perspective Discussions

Multiple perspectives will be explored to help understand the approval of Chinese cell therapy products, including novel technologies, manufacturing processes, quality control, registration and evaluation.

Panoramic View

Panoramic View of cell therapy will be presented in the main venue and the 5 sessions by the first-class speakers.

Face-to-face Communication

Opportunities of face-to-face communication with top-ranked experts will be provided to promote the cooperation among enterprises focused on cell therapy.